Nine Square Therapeutics, founded by ATP and leading scientists at UCSF, is discovering and delivering novel small-molecule therapeutics for movement disorders including Parkinson’s, ALS, essential tremors, and dyskinesias. Nine Square applies leading capabilities in computational chemistry, biophysics, and computational biology and a machine-learning-enabled cell profiling platform for target identification, chemical optimization, and patient stratification.